K WAVE MEDIA LTD. (KWMWW)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Arrowhead Pharmaceuticals to Participate in Upcoming May 2026 Events
BRIDGEBIO PHARMA, INC. (BBIO)
BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026
NEUROCRINE BIOSCIENCES INC (NBIX)
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-2118, a Corticotropin-Releasing Factor Type 2 Receptor Agonist
DANAOS CORP (DAC)
Danaos Corporation Announces Date for the Release of First Quarter 2026 Results, Conference Call and Webcast
MARZETTI CO (MZTI)
The Marzetti Company Reports Third Quarter Sales and Earnings
GLOBAL BUSINESS TRAVEL GROUP, INC. (GBTG)
Long Lake Agrees to Acquire American Express Global Business Travel, the World’s Largest Corporate Travel Platform, for $6.3 Billion, With Support From General Catalyst and Alpha Wave
WESTERN UNION CO (WU)
Western Union Launches USDPT on Solana Advancing Regulated Digital Infrastructure for Global Payments
MACROGENICS INC (MGNX)
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
PROPETRO HOLDING CORP. (PUMP)
ProPetro Holding Corp. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure
PALVELLA THERAPEUTICS, INC. (PVLA)
Palvella Therapeutics Announces First Patients Dosed in Phase 2 LOTU Trial of Fast Track-Designated QTORIN™ Rapamycin for Clinically Significant Angiokeratomas
FOSTER L B CO (FSTR)
L.B. Foster Company Announces Strong Sales Growth and Profitability Expansion in 2026 First Quarter; Reaffirms Full Year 2026 Financial Guidance
DEFI TECHNOLOGIES, INC. (DEFT)
DeFi Technologies Announces Shareholder Call to Discuss Q1 2026 Financial Results USA - English Deutschland - Deutsch Deutschland - English
INFLARX N.V. (IFRX)
InflaRx Reports Favorable Reactive Metabolite Profile for Izicopan in Human Liver Microsomes